Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,823,743 papers from all fields of science
Search
Sign In
Create Free Account
omadacycline
Known as:
(4S,4aS,5aR,12aS)-4,7-bis(dimethylamino)-9-{[(2,2-dimethylpropyl)amino]methyl}- 3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Omadacycline:Susc:Pt:Isolate:OrdQn:MIC
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Clinical Efficacy of Omadacycline
R. Ellison
2019
Corpus ID: 86658581
Omadacycline is a new-generation tetracycline approved by the FDA in the fall of 2018 (NEJM JW Infect Dis Dec 2018 and Nuzyra…
Expand
2019
2019
Pharmaceutical Approval Update.
M. Kaufman
P & T : a peer-reviewed journal for formulary…
2019
Corpus ID: 73421350
Arikayce (amikacin liposome inhalation suspension) for Mycobacterium avium complex lung disease; Xofluza (baloxavir marboxil) for…
Expand
Review
2018
Review
2018
Return of the tetracyclines: omadacycline, a novel aminomethylcycline antimicrobial.
J. C. Cho
,
L. Childs‐Kean
,
M. Zmarlicka
,
M. Crotty
Drugs of Today
2018
Corpus ID: 21732566
Omadacycline is a novel aminomethylcycline antimicrobial agent that is available in both oral and intravenous formulations. The…
Expand
2018
2018
Omadacycline for Acute Bacterial Skin and Skin Structure Infections: Integrated Analysis of Randomized Clinical Trials.
F. Abrahamian
,
G. Sakoulas
,
+5 authors
P. Mcgovern
American health & drug benefits
2018
Corpus ID: 261351950
ABSSSI = acute bacterial skin and skin structure infections; ECR = early clinical response; EMA = European Medicines Agency; FDA…
Expand
2018
2018
FDA to consider omadacycline
D. Staff
2018
Corpus ID: 132714076
In October, the Food and Drug Administratin is expected to decide on the approval of omadacycline (Paratek Pharmaceuticals) for…
Expand
2018
2018
FDA Approves Omadacycline for CABP and ABSSSI
G. Sakoulas
2018
Corpus ID: 81051115
On October 2, 2018, the U.S. FDA approved omadacycline (Nuzyra) for the treatment of acute bacterial skin and skin structure…
Expand
2017
2017
Efficacy and Safety of Omadacycline in Intravenous Drug Using (IVDU) and Hepatitis C-Positive (HCV+) Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): A Subgroup Analysis…
C. Ohl
,
N. Cure-Bolt
,
S. Chitra
,
E. Tzanis
,
P. Mcgovern
2017
Corpus ID: 80026671
ACKNOWLEDGMENTS REFERENCES • Omadacycline (OMC), the first aminomethylcycline antibiotic to reach late-stage clinical development…
Expand
2017
2017
Pipeline antibiotic omadacycline shows promise against MRSA and more
L. Hilton
2017
Corpus ID: 79477200
Phase 3 data for Paratek Pharmaceuticals’ once-daily treatment with IV-to-oral omadacycline has shown the pipeline drug…
Expand
Review
2015
Review
2015
[New antibacterial agents on the market and in the pipeline].
W. Kern
Der Internist
2015
Corpus ID: 34076115
After some years of stagnation there have been several new successful developments in the field of antibacterial agents. Most of…
Expand
2015
2015
Neue Antibiotika auf dem Markt und in Entwicklung
W. Kern
Der Internist
2015
Corpus ID: 24249178
ZusammenfassungNach Jahren der Stagnation sind inzwischen wieder zahlreiche Neuentwicklungen im Bereich der antibakteriellen…
Expand